HMC Partners with AbbVie to Enhance Clinical Research Program
Doha: Hamad Medical Corporation (HMC) has signed a Memorandum of Understanding (MoU) with AbbVie Biopharmaceuticals Gulf Levant to implement the Clinical Research Advancement Integrated Signature Program (CRISP) at HMC. The initiative is designed to p…